China Pharma vs PMGC
CPHI and ELAB side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CPHI and ELAB compare
China Pharma is the larger company, worth 1.8 times as much as PMGC ($23.4M against $12.8M).
China Pharma keeps more of each dollar of sales as profit, with a net margin of −114% compared with −523% at PMGC.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CPHI | ELAB |
|---|---|---|
| Size and price | ||
| Market cap | $23.4M | $12.8M |
| Share price | $0.543 | $1.58 |
| Change, 1 year | −64.5% | −99.9% |
| Change, 5 years | −99.8% | – |
| Beta (5Y) | 0.89 | 1.69 |
| Employees | 221 | 32 |
| StockData Score | ||
| Total score | 4 | 4 |
| Valuation score | 1 | 3 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 6.0× | 5.0× (better) |
| P/B | 0.6× (better) | 0.8× |
| Fair value | – | $3.13 |
| Margin of safety | – | 49.5% |
| Growth | ||
| Revenue growth (TTM) | −11.0% | – |
| Revenue growth, 5Y average | −17.5% | – |
| Profitability | ||
| Gross margin | 11.8% | 31.1% (better) |
| Operating margin | −112% | – |
| Net margin | −114% (better) | −523% |
| Return on equity | −21.0% (better) | −105% |
| Return on invested capital | −15.5% | – |
| Financial health | ||
| Debt / equity | 0.05 | – |
| Interest coverage | −136.5× | – |
| Current ratio | 0.26 | 1.36 (better) |
| Altman Z-score | −0.30 (better) | −0.47 |
| Piotroski F-score | 6 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 0.47% | 0.33% |
| Held by insiders | 0.00% | 55.2% |
| Short interest, % of float | 0.21% | 0.51% |
Go deeper
- CPHI stock overview
- CPHI income statement
- CPHI valuation and score
- ELAB stock overview
- ELAB income statement
- ELAB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.